NRx Pharmaceuticals Completes Manufacturing Validation for Preservative-Free Ketamine

Bitget2026/10/19 12:34

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

NRx Pharmaceuticals completed three commercial-scale process validation lots of preservative-free ketamine, meeting FDA good manufacturing practice requirements.
Two-year room-temperature stability testing showed no deterioration in purity, potency or sterility without preservatives.
Commercially releasable supply is available pending FDA approval of its abbreviated new drug application, with a November 10, 2026, target date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRX Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610190830PRIMZONEFULLFEED9848100) on October 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NRx Pharmaceuticals Completes Manufacturing Validation for Preservative-Free Ketamine

You may also like

Crypto prices